Microbicide Acceptability Among High-Risk Urban U.S. Women: Experiences and Perceptions of Sexually Transmitted HIV Prevention

Weeks, Margaret R.; Mosack, Katie E.; Abbott, Maryann; Sylla, Laurie; Valdes, Barbara; Prince, Mary

doi:10.1097/01.olq.0000143113.04524.a5

Cited by 52 publications

(72 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However this observation, This study suggests that professionals would support which challenges the widely acknowledged power female-controlled HIV/STI prevention options particularly imbalance with respect to sexual decisions in favor of the the vaginal microbicides, a finding which is similar to earlier 23 12,13, [22][23][24] men, should be interpreted with caution. It is likely that this reports from other parts of the world.…”

Section: Discussionsupporting

confidence: 46%

Acceptability of female-controlled HIV/STI prevention options among professionals in Dhaka, Bangladesh

Ara¹,

Begum²,

Nweneka

2013

SE Asia J. Pub. Health

View full text Add to dashboard Cite

Millions of women worldwide lack the power to protect themselves from HIV; current prevention options require cooperation from the male partners. Limited prospects for an HIV vaccine and continued escalation of HIV make female-controlled HIV/STI prevention options like microbicides desirable. While socio-cultural factors could reduce acceptability of these options by vulnerable women, opinion leaders like health personnel and teachers could positively influence their acceptability. The aim of this study was to assess the acceptability of female-controlled HIV/STI prevention options among medical doctors, nurses, pharmacists and secondary school teachers in Dhaka, Bangladesh. A cross-sectional study was conducted using a self-administered semi-structured questionnaire among 375 professionals (nurses, doctors, pharmacists and teachers). The questionnaire assessed the respondents perception of HIV, and their attitudes towards female-controlled HIV/STI prevention options such as female condoms and vaginal microbicides. The study revealed that 98.4% of the respondents were of the opinion that women should determine their HIV/STI prevention options, while 89.3% agreed that options which empower women would be acceptable. It was also found that 18.4% would use the female condoms while 34.4% would use vaginal microbicides. Factors associated with willingness to use the female-controlled prevention options were HIV risk perception, marital status, profession, and duration in profession. There was no association between willingness to use female condoms and willingness to use the vaginal microbicides. While male condom use was positively associated with willingness to use female condom, there was no significant relationship between male condom use and willingness to use the vaginal microbicides. The study showed that professionals strongly supported HIV/STI prevention options that are female-controlled, with most preferring vaginal microbicides to the female condoms. Such support would inform the design of appropriate interventions to prepare the professionals for the eventual advent of an effective microbicide as a HIV/AIDS prevention option.South East Asia J Public Health | Jan-June 2012 | Vol 2 Issue 1 | 46-53 DOI: http://dx.doi.org/10.3329/seajph.v2i1.15265

show abstract

Section: Discussionsupporting

confidence: 46%

Acceptability of female-controlled HIV/STI prevention options among professionals in Dhaka, Bangladesh

Ara¹,

Begum²,

Nweneka

2013

SE Asia J. Pub. Health

View full text Add to dashboard Cite

show abstract

“…Young women (aged 15-24 years) bear a disproportionate burden of HIV infection, have an infection rate up to eight times higher than their male peers (Dellar, Dlamini, and Abdool Karim 2015), and acquire HIV infection at least five to seven years earlier than men (UNAIDS 2015). Several studies emphasise the biological (Dellar, Waxman, and Abdool Karim 2015;McKinnon and Abdool Karim 2016) and sociocultural complexities (Ackermann and Klerk 2002;Ogunlela 2014;Prince et al 2005;Weeks et al 2004) through which women negotiate safe-sex practices or condom use with their male partners. However, most available safer sex options require male co-operation.…”

Section: Introductionmentioning

confidence: 99%

Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa

Govender

Mansoor

MacQueen

et al. 2017

Culture, Health & Sexuality

View full text Add to dashboard Cite

The release of World Health Organisation guidelines recommending the prophylactic use of daily Truvada ® for all populations at high risk of acquiring HIV opens the way for implementation of oral pre-exposure prophylaxis (PrEP). The impact of new prevention technologies is, however, dependent on demand creation strategies such as user awareness, acceptability and access, which in turn are influenced by sociocultural and gender norms. This study was conducted in three locations in KwaZulu-Natal, urban, rural and peri-urban, with six participatory workshops. Knowledge, desirable features of a product and demand positioning for PrEP were assessed using a participatory action media research process which included art-based activities and group discussion using a semi-structured interview schedule. The data were analysed using thematic analysis. The key themes that emerged in relation to product adoption were: ability to maintain secrecy of product use; the need for agency with personal choices around HIV prevention; and an increased desire for HIV protection. Findings reaffirm the influence of user engagement in understanding the sociocultural dynamics that influence demand creation for PrEP adoption.

show abstract

“…Therefore, survey items addressed issues found to be related to microbicide acceptability in other studies, including those that might increase or decrease microbicide acceptability. 3,5 For these items, women were asked: Suppose a new vaginal capsule was available for women to use. For each of the following characteristics, please indicate whether you would be more likely to use the product, less likely to use, or neutral.…”

Section: Methodsmentioning

confidence: 99%

“…[3][4][5][6][7][8][9][10][11][12][13][14][15] These studies suggest that several factors may influence microbicide acceptability, including a woman's sociodemographic characteristics, personal risk (real or perceived), cultural norms and practices, side effects, and the smell or taste of a product. [3][4][5][6][7][8][9][10][11][12][13][14][15] An increased understanding of which attributes of a microbicide are most appealing to women at increased risk for STDs may help ensure that effective products are used.…”

mentioning

confidence: 99%

Preferred Characteristics of Vaginal Microbicides in Women with Bacterial Vaginosis

Cook

Downs

Marrazzo

et al. 2009

Journal of Women's Health

View full text Add to dashboard Cite

Background: Vaginal microbicides have the potential to reduce HIV=STD acquisition when used consistently. Our objectives were to determine product attributes associated with willingness to use a vaginal microbicide and whether product preferences varied according to participant characteristics. Methods: Women (n ¼ 408) with bacterial vaginosis (BV) were recruited as part of a randomized trial to prevent BV. Participants completed a survey interview that assessed demographic information, sexual history, and douching behavior. To assess microbicide preferences, women rated whether specific product attributes would make them more or less likely to use a vaginal microbicide. Principal components analyses revealed two major groupings for the product attribute items. We determined the relative importance of each group of product attributes and whether the importance of the different groupings varied among subgroups of women. Results: The participants' mean age was 24 years (range 14-45), 64% were black, and 74% were unmarried. Overall, participants reported being most likely to use a vaginal product with protection properties (2.54), whereas they were nearly neutral regarding side effects (0.56). The individual product attributes, could prevent BV, could prevent vaginal odor (2.72), and could prevent vaginal itching and burning (2.61), were rated similarly or slightly higher than could reduce the risk of getting an STD (2.58) or could reduce the risk of getting HIV (2.44). In multivariate analyses, protection attributes were rated significantly higher among older women and marginally higher in women with a greater number of lifetime sexual partners. Younger women were most likely to report that side effects would affect their likelihood of using the product. Conclusions: Women with BV rated potential protection features of a vaginal microbicide higher than side effects. A product's personal hygiene aspects were rated equally or more important than the product's ability to prevent HIV=STD infections. Younger women may respond to different factors that influence product acceptability and adherence.

show abstract

Microbicide Acceptability Among High-Risk Urban U.S. Women: Experiences and Perceptions of Sexually Transmitted HIV Prevention

Abstract: Vaginal microbicides may improve prevention outcomes for high-risk inner-city women.

Cited by 52 publications

References 22 publications

Acceptability of female-controlled HIV/STI prevention options among professionals in Dhaka, Bangladesh

Acceptability of female-controlled HIV/STI prevention options among professionals in Dhaka, Bangladesh

Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa

Preferred Characteristics of Vaginal Microbicides in Women with Bacterial Vaginosis

Contact Info

Product

Resources

About